- ICH GCP
- Rejestr badań klinicznych w USA
- Badanie kliniczne NCT01820598
Phase II Study of Neuromuscular Electrical Multisite System on Cardiovascular Effects in Severe Obese Patients (StimobII)
Acute and Medium-term Effects of Neuromuscular Electrical Multisite System (Kneehab®) on Cardiovascular Parameters and Induced Muscle Fatigue in Morbidly Obese Patients: Comparison With the Unidirectional Standard Device
The study was designed to test the following hypotheses:
In patients with severe obesity, a multisite electrostimulation session (m-NMES) will induce higher changes in metabolic, inflammatory and cardiovascular parameters and higher increase in muscle strength during stimulated contractions than conventional unidirectional electrostimulation session (c-NMES).
In patients with severe obesity, a six-weeks m-NMES training program will enhance cardiovascular, metabolic and inflammatory parameters.
Przegląd badań
Status
Interwencja / Leczenie
Szczegółowy opis
Background: Physical activity is known to reduce cardiovascular risk as far as even minor change in lifestyle could occur. In obesity, physical activity programs remain challenging due to multifactorial causes related to body mass such as shortness of breath, traumatological pain or psychosocial causes. Although neuromuscular electrical stimulation training is presently ignored in the management of obesity, this technique may be appropriate and useful for muscle deconditioning in these patients. Furthermore, direct effects of electrostimulation training program on vascular function have been previously reported in spinal cord injury and chronic heart disease, suggesting that improvement in cardiovascular function may be expected. While a promising new technique of multisite electrical stimulation (the Kneehab® system) has been recently commercialized, few study have investigated the acute effects of electrostimulation on vascular function and not any study report the effects of electrical stimulation in obese patients.
MAIN OUTCOME OF THE ACUTE PHASE STUDY (1st part):To study the effect of multisite electrical stimulation session (m-NMES) on arterial stiffness as compared to conventional unidirectional electrical stimulation session (c-NMES) in patients with severe obesity. Secondary outcomes of the observational study: 1/ To study the effect of m-NMES on endothelial function, blood pressure, systemic inflammation and metabolic status (fasting glucose and insulin) as well as electrically-induced muscle fatigue as compared with c-NMES in patients with morbid obesity. 2/ To study the profile of responders to electrical stimulation according to body composition, 6-minute walking distance, spontaneous physical activity or susceptibility to tolerate electrical stimulation. Response to electrical stimulation will be assessed by an improvement in arterial stiffness after stimulation, if so.
MAIN OUTCOME OF THE INTERVENTIONAL STUDY (2nd part):To study the effect of a multisite electrical stimulation training program (m-NMES) (6 weeks, 30 sessions) on arterial stiffness in patients with severe obesity. Secondary outcomes of the interventional study: To study the effect of m-NMES on endothelial function, blood pressure, systemic inflammation and metabolic status (fasting glucose and insulin) as well as muscle strength, body composition, functional capacity (6-minute walking distance) and spontaneous physical activity, after 15 sessions (3 weeks) and after 30 sessions (6 weeks) of training program. Evaluation of the dose-response to m-NMES training in terms of arterial stiffness and functional capacity.
Expected outcomes: Acute change in arterial stiffness and/or endothelial function is expected after one m-NMES session and/or after c-NMES session. M-NMES session is expected to induce higher changes than c-NMES stimulation session on cardiovascular and muscle parameters. Chronic changes in arterial stiffness and/or endothelial function is expected after 6 weeks of m-NMES training.
Typ studiów
Zapisy (Oczekiwany)
Faza
- Nie dotyczy
Kontakty i lokalizacje
Lokalizacje studiów
-
-
-
Grenoble, Francja
- Rekrutacyjny
- Hopital Universitaire
-
Kontakt:
- Jean-Louis Pepin, MD, PhD
- Numer telefonu: 0476765516
- E-mail: JPepin@chu-grenoble.fr
-
Kontakt:
- Isabelle, Vivodtzev, PhD
- Numer telefonu: 0476510304
- E-mail: i.vivodtzev@agiradom.com
-
-
Kryteria uczestnictwa
Kryteria kwalifikacji
Wiek uprawniający do nauki
Akceptuje zdrowych ochotników
Płeć kwalifikująca się do nauki
Opis
Inclusion Criteria:
- Male or female, aged over 18 years
- Morbid obesity (BMI > 35 kg/m²)
- Not included into exercise training program in the year prior to inclusion- Spontaneous physical activity lower than 160 min wk (i.e. < 30 min/d x 5 d/wk).
Additional Inclusion criteria for the interventional study:
- Patients with PWV > 9.3 m / s
Exclusion Criteria:
- Underage- Pregnant or parturient women
- Persons deprived of their liberty for judicial or administrative reasons, person under a legal protection measure (article L1121-8)
- Exclusion period in other studies- Person not affiliated to a social security scheme
- Chronic alcoholism
Plan studiów
Jak projektuje się badanie?
Szczegóły projektu
- Główny cel: Leczenie
- Przydział: Randomizowane
- Model interwencyjny: Zadanie krzyżowe
- Maskowanie: Pojedynczy
Broń i interwencje
Grupa uczestników / Arm |
Interwencja / Leczenie |
---|---|
Inny: m-NMES first
Multisite electrostimulator first (Visit 1) and conventional electrostimulator then (Visit 2)
|
Inne nazwy:
|
Inny: c-NMES first
Conventional electrostimulator first (Visit 1) and multisite electrostimulator then (Visit 2)
|
Inne nazwy:
|
Co mierzy badanie?
Podstawowe miary wyniku
Miara wyniku |
Opis środka |
Ramy czasowe |
---|---|---|
Delta arterial stiffness
Ramy czasowe: Day1 and Day3
|
Change in carotid-femoral Pulse wave velocity (PWV) after NMES sessions
|
Day1 and Day3
|
Miary wyników drugorzędnych
Miara wyniku |
Opis środka |
Ramy czasowe |
---|---|---|
Delta pulse arterial tonus (RH-PAT)
Ramy czasowe: Day1 and Day3
|
change in pulse arterial tonometry after NMES sessions
|
Day1 and Day3
|
NMES-induced muscle fatigue
Ramy czasowe: Day1 and Day3
|
change in maximal voluntary contraction after NMES sessions
|
Day1 and Day3
|
Delta blood pressure
Ramy czasowe: Day1 and Day3
|
changes in systolic and diastolic blood pressures after NMES sessions
|
Day1 and Day3
|
Delta plasmatic biomarkers
Ramy czasowe: Day1 and Day3
|
changes in inflammatory and metabolic plasmatic biomarkers after NMES sessions
|
Day1 and Day3
|
Body composition
Ramy czasowe: Day1, Day21 and Day 42
|
Fat-free mass and fat-free mass indexes assessed by impedancemetry
|
Day1, Day21 and Day 42
|
Spontaneous physical activity
Ramy czasowe: Day1 and Day 42
|
Number of hours per day of physical activity at 1, 2, 3, 4 or 5 metabolic equivalent(METS),Number of step per day,using a 7-days actigraphy
|
Day1 and Day 42
|
Maximal voluntary contraction
Ramy czasowe: Day1, Day21 and Day 42
|
Quadriceps peak force
|
Day1, Day21 and Day 42
|
Walking distance
Ramy czasowe: Day1 and Day 42
|
6-minute-walking test
|
Day1 and Day 42
|
Arterial stiffness
Ramy czasowe: Day1, Day21 and Day 42
|
Pulse wave velocity (PWV) measurements
|
Day1, Day21 and Day 42
|
Pulse artery tone (RH-PAT)
Ramy czasowe: Day1, Day21 and Day 42
|
Pulse artery tonometry measurement
|
Day1, Day21 and Day 42
|
Plasmatic biomarkers
Ramy czasowe: Day1, Day21 and Day 42
|
Inflammatory and metabolic biomarkers
|
Day1, Day21 and Day 42
|
Blood pressure
Ramy czasowe: Day1, Day21 and Day 42
|
Arterial systolic and diastolic blood pressure
|
Day1, Day21 and Day 42
|
Response to m-NMES
Ramy czasowe: Day42
|
Delta in current intensity during m-NMES between the first to the last session
|
Day42
|
Współpracownicy i badacze
Sponsor
Współpracownicy
Śledczy
- Główny śledczy: Jean-Louis Pépin, MD, PhD, Laboratoire EFCR, CHU de Grenoble, 38043, Grenoble, France
Daty zapisu na studia
Główne daty studiów
Rozpoczęcie studiów
Zakończenie podstawowe (Oczekiwany)
Ukończenie studiów (Oczekiwany)
Daty rejestracji na studia
Pierwszy przesłany
Pierwszy przesłany, który spełnia kryteria kontroli jakości
Pierwszy wysłany (Oszacować)
Aktualizacje rekordów badań
Ostatnia wysłana aktualizacja (Oszacować)
Ostatnia przesłana aktualizacja, która spełniała kryteria kontroli jakości
Ostatnia weryfikacja
Więcej informacji
Terminy związane z tym badaniem
Inne numery identyfikacyjne badania
- 12-AGIR-04
Te informacje zostały pobrane bezpośrednio ze strony internetowej clinicaltrials.gov bez żadnych zmian. Jeśli chcesz zmienić, usunąć lub zaktualizować dane swojego badania, skontaktuj się z register@clinicaltrials.gov. Gdy tylko zmiana zostanie wprowadzona na stronie clinicaltrials.gov, zostanie ona automatycznie zaktualizowana również na naszej stronie internetowej .